Quart Barry D's Form 4 filing
Kiniksa Pharmaceuticals International, plc (KNSA) · filed Jun 11, 2025
- Accession no.
- 0001415889-25-016724
- Filed
- Jun 11, 2025
- Trade date
- Jun 9-11, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $833.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Quart Barry DCIK 0001384243 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 9, 2025 | Class A Ordinary Share | MOption exerciseAcquired | +6,900 | $3.80 | +$26,220 | 19,446 | Direct | |
| Jun 9, 2025 | Class A Ordinary Share | SSaleDisposed | −6,900 | $30.26 | −$208,794 | 12,546 | Direct | |
| Jun 10, 2025 | Class A Ordinary Share | MOption exerciseAcquired | +8,212 | $3.80 | +$31,205.6 | 20,758 | Direct | |
| Jun 10, 2025 | Class A Ordinary Share | SSaleDisposed | −8,212 | $30.36 | −$249,316.32 | 12,546 | Direct | |
| Jun 11, 2025 | Class A Ordinary Share | MOption exerciseAcquired | +12,336 | $3.80 | +$46,876.8 | 24,882 | Direct | |
| Jun 11, 2025 | Class A Ordinary Share | SSaleDisposed | −12,336 | $30.39 | −$374,891.04 | 12,546 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 9, 2025 | Class A Ordinary Share | MOption exerciseDisposed | −6,900 | $0.00 | $0 | 20,548 | Direct | |
| Jun 10, 2025 | Class A Ordinary Shares | MOption exerciseDisposed | −8,212 | $0.00 | $0 | 12,336 | Direct | |
| Jun 11, 2025 | Class A Ordinary Shares | MOption exerciseDisposed | −12,336 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.